About Xsphera Biosciences
Xsphera Biosciences is a private company based in Boston, Massachusetts, incorporated in 2018 in Delaware. It has reported $12,700,067 raised in two offerings on Form D since June 2022. Its chief executive is Stephen Remondi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 24, 2023 | May 4, 2023 | $12,600,067of $19.8M target | 40 | $315K | EquityRule 506(b) | Form D ↗ |
| May 31, 2022 | Jun 16, 2022 | $100,000of $3.0M target | 1 | $100K | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $12,700,067 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Xsphera Biosciences's Form D filed May 4, 2023.
SR
Stephen Remondi
CEO and director
RW
Robert Walsh
Director